宫内暴露于母亲SARS-CoV-2感染的3岁儿童神经发育结局
该回顾性队列研究纳入2020年3月1日至2021年5月31日在Mass General Brigham医疗系统分娩的18,124例活产,暴露为孕期SARS-CoV-2聚合酶链反应检测阳性。暴露组140/861例(16.3%)在36月龄前获神经发育诊断,非暴露组1,680/17,263例(9.7%),校正后OR 1.29(95%CI 1.05-1.57,P=.01)。结论认为孕期SARS-CoV-2感染与3岁前不良神经发育诊断风险增加相关,效应在第三孕期暴露及男性子代中更明显。
要点
- 暴露组16.3%(140/861)与非暴露组9.7%(1,680/17,263)在36月龄前获神经发育诊断。
- 校正后OR 1.29(95%CI 1.05-1.57,P=.01),第三孕期暴露aOR 1.36(95%CI 1.07-1.72,P=.01)。
- 男性子代aOR 1.43(95%CI 1.05-1.91,P=.02),作者强调对暴露儿童长期神经发育监测的重要性。
核心结论
- 孕期母亲SARS-CoV-2感染与3岁前不良神经发育诊断风险增加相关,效应在第三孕期暴露及男性子代中更明显。
- 作者认为这些发现凸显了对SARS-CoV-2暴露儿童进行长期神经发育监测的重要性。
研究设计与样本
- 回顾性队列研究,纳入2020年3月1日至2021年5月31日在Mass General Brigham医疗系统分娩的18,124例活产。
- 采用logistic回归模型校正母亲年龄、种族和民族、保险类型、医院类型及早产。
主要发现
- 暴露组861例中140例(16.3%)在36月龄前获神经发育诊断,非暴露组17,263例中1,680例(9.7%)。
- 未校正OR 1.80(95%CI 1.49-2.17),校正后OR 1.29(95%CI 1.05-1.57,P=.01)。
- 敏感性分析中第三孕期暴露总体aOR 1.36(95%CI 1.07-1.72,P=.01)。
- 男性子代aOR 1.43(95%CI 1.05-1.91,P=.02)。
临床怎么用
- 作者认为这些发现凸显了对SARS-CoV-2暴露儿童进行长期神经发育监测的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To determine whether in utero exposure to maternal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is associated with increased risk of adverse neurodevelopmental outcomes in children by age 3 years. METHODS: We conducted a retrospective cohort study of 18,124 live births to individuals who delivered between March 1, 2020, and May 31, 2021, within the Mass General Brigham health system. The exposure of interest was maternal SARS-CoV-2 infection , defined as a positive SARS-CoV-2 polymerase chain reaction test result during pregnancy. The outcome of interest was presence of any neurodevelopmental diagnosis up to 36 months after birth, identified using International Statistical Classification of Diseases and Related Health Problems, Tenth Revision diagnostic codes. To evaluate the association between SARS-CoV-2 exposure in pregnancy and these diagnoses, we used logistic regression models adjusting for maternal age, race and ethnicity, insurance type, hospital type, and preterm birth. RESULTS: Among the 861 individuals with SARS-CoV-2-exposed pregnancies (4.8%), 140 offspring (16.3%) received a neurodevelopmental diagnosis by 36 months after birth, compared with 1,680 of 17,263 unexposed offspring (9.7%) (unadjusted odds ratio 1.80, 95% CI, 1.49-2.17; adjusted odds ratio [aOR] 1.29, 95% CI, 1.05-1.57, P =.01). In sensitivity analyses, largest effects were observed in third-trimester exposures, overall (aOR 1.36, 95% CI, 1.07-1.72, P =.01), and among male offspring (aOR 1.43, 95% CI, 1.05-1.91, P =.02). CONCLUSION: Maternal SARS-CoV-2 infection in pregnancy was associated with increased risk of adverse neurodevelopmental diagnoses by age 3 years, with effects most pronounced after third-trimester exposure and in male offspring. These findings highlight the importance of long-term neurodevelopmental monitoring for SARS-CoV-2-exposed children.
引用
- Shook LL, Castro V, Ibanez-Pintor L, et al. Neurodevelopmental Outcomes of 3-Year-Old Children Exposed to Maternal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Utero. Obstet Gynecol. 2025. PMID: 41166717. doi:10.1097/AOG.0000000000006112
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。